Harnessing Metal Nanoparticles: Revolutionizing Cancer Therapy Through Targeted Drug Delivery and Tumor Microenvironment Modulation
Abstract
Cancer remains a significant global health burden, claiming countless lives annually and incurring substantial direct and indirect economic costs. Despite advancements in therapeutic modalities, conventional cancer treatments, including chemotherapy, radiotherapy and surgery, are often hampered by limitations such as insufficient efficacy, dose-dependent side effects, high costs and patient tolerability. This has spurred extensive research into novel therapeutic approaches for this life-threatening disease. Metal nanoparticles (MNPs) have emerged as promising tools in cancer therapy due to their unique physicochemical properties spanning the past two decades. Owing to their size similarity to biological molecules, MNPs possess the inherent ability to penetrate cellular barriers, making them ideal carriers for targeted drug delivery. These multifunctional nanoplatforms offer distinct advantages over conventional therapeutics by enabling targeted delivery of anticancer agents to specific tumor sites, thereby enhancing therapeutic efficacy and minimizing systemic side effects. Photodynamic therapy and sonodynamic therapy represent particularly promising strategies that leverage MNPs for cancer treatment. This review delves into the potential applications of MNPs in modulating the tumor microenvironment, paving the way for the exploration of this vast and rapidly evolving field of nanomedicine.
